Dunbar Pharma to Showcase European Dronabinol Supply Capabilities at expopharm 2026 in Munich

Contributed by: Business Wire

Logo

Images

Dunbar Pharma to Showcase European Dronabinol Supply Capabilities at expopharm 2026 in Munich

Business Wire embedded0

Tags

Cannabis

Biotechnology

Other Health

Alternative Medicine

Managed Care

Health

Pharmaceutical

General Health

Natural Resources

Dunbar Pharmaceuticals

More Like This

Dunbar Pharma Plant-Based WaterClear THC™

Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

Tilray Expands Medical Cannabis Portfolio in Germany

Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development

Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances

Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings